4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}benzamide(CAS: 641571-10-0)

4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(3-pyridinyl)-2-pyrimidinyl]amino}benzamide (CAS: 641571-10-0) is a complex organic compound with a molecular formula of C28H24F3N5O2. It contains multiple heterocyclic rings, including a pyrimidine and imidazole, making it a potential candidate for pharmaceutical development. The compound is known for its structural complexity and is often used in research for its biological activity and chemical versatility.

This compound is primarily used in pharmaceutical research as a potential inhibitor of specific enzymes. Its molecular structure, featuring a benzamide backbone and multiple aromatic rings, makes it suitable for drug development targeting metabolic disorders and cancer. It may also find applications in chemical synthesis and as a lead compound for further modification.

While specific toxicity data for this compound may not be widely published, it is generally considered to have moderate toxicity based on its chemical structure. Handling should be done with appropriate protective measures, such as gloves and goggles, and in a well-ventilated area. Safety standards suggest it should be treated as a potential hazardous substance during experimental use.

This compound should be stored in a cool, dry, and dark place, ideally at 2-8°C. It is sensitive to moisture and light, so it must be kept in a sealed container with desiccant. Storage in a well-ventilated area is recommended to prevent exposure to air, and it should be protected from any potential sources of contamination or degradation.